17th Aug Current Affairs News Analysis | Prelims & Mains 2020
“Real difficulties can be overcome; it is only the imaginary ones that are unconquerable.” –Theodore N. Vail

Page Contents:
BRICS Anti-Drug Working Group
HEADLINES:
4th Meeting of the BRICS Anti-Drug Working Group held
WHY IN NEWS:
Communiqué adopted reaffirming commitment of the five member states to the International Anti-drug conventions
SYLLABUS COVERED: GS 2 : Last BRICS Summit : BRICS
ISSUE:
BRICS ANTI-DRUG WORKING GROUP
FOCUS
- India called for nodal points to enable real-time information sharing among BRICS nations
VENUE
- This year’s session, held over video conference on August 12, 2020, was chaired by Russia.
FRUITFUL EXCHANGE OF OPINIONS ON
- The drug situation in the BRICS states.
- The international and regional trends of illegal trafficking in narcotic drugs.
- Psychotropic substances and their precursors.
DELIBERATIONS
- The impact of various internal and external factors on the situation took place during the summit.
- The common points emerged during the discussions include need for real time information sharing among the member states.
IASbhai WINDUP:
- BRICS is an informal group of states comprising the Federative Republic of Brazil, the Russian Federation, the Republic of India, the People’s Republic of China and the Republic of South Africa.
- The growing economic might of BRICS countries, their significance as one of the main driving forces of global economic development.
- Among other areas of collaboration, matters pertaining to drug trafficking is an important area of cooperation among the BRICS member states.
SOURCES:THE HINDU & PIB | 17th Aug Current Affairs News Analysis
T cell immunity
HEADLINES:
T cell immunity prevents recurrent severe COVID-19 disease
WHY IN NEWS:
SYLLABUS COVERED: GS 3: Science
ISSUE:
The study published by a team led by Marcus Bugger from Karolinska Institute, Stockholm, Sweden.
T CELL RESPONSE
- This is because, once infected with SARS-CoV-2, the immune system elicits “robust, broad and highly functional memory T cell responses”.
- SARS-CoV-2-specific T cells even in family members who have been exposed to the virus but have tested negative on antibody blood tests.
ROBUST RESPONSES
- All categories of people — recovered from moderate or severe COVID-19 disease.
- This indicates a “previously unanticipated degree of population-level immunity against COVID-19”.
- Studies undertaken in rhesus macaques had found that once infected, the animals were fully protected from reinfection.
IASbhai WINDUP:
- This implies that seroprevalence as an indicator may underestimate the extent of immunity in the population.
- “The dissociation of antibody (its absence) and a robust T cell response is noteworthy.
SOURCES:THE HINDU & PIB | 17th Aug Current Affairs News Analysis
SalivaDirect
HEADLINES:
U.S. FDA nod for rapid, inexpensive saliva test
WHY IN NEWS:
It assures high accuracy in detecting the presence of virus
SYLLABUS COVERED: GS 3: Diseases
ISSUE:
SALIVADIRECT
DEVELOPED BY
- The inexpensive test, called SalivaDirect, developed by a team from the Yale School of Public Health.
FEATURES
- It has high sensitivity and can detect the virus even when the number of virus copies in the saliva sample is as low as 6-12 copies per microlitre.
- The sensitivity of the new test was about 93%, according to a preprint posted on medRxiv.
Collecting and testing saliva samples involves three steps —
- Collecting saliva without preservative buffers
- Proteinase K treatment and heat inactivation
- Dualplex RT-qPCR virus detection.
The study also found less variability in results with the self-sample collection of saliva.
IASbhai WINDUP:
OPEN SOURCE PROTOCOL
- The testing protocol has been provided as an “open source”.
- Thus, SalivaDirect will be free to use by diagnostic labs.
- NGOs may apply for a licence.
- The researchers validated SalivaDirect using several common and available reagents.
- They claim the test is inexpensive costing between $1.29-4.37 per sample.
SOURCES:THE HINDU & PIB | 17th Aug Current Affairs News Analysis
DISCOVER MORE : Important Daily Current Affairs for UPSC PRELIMS 2020
If you liked this article, then please subscribe to our YouTube Channel for Daily Current Affairs , Editorial Analysis & Answer writing video tutorials. You can also find us on Twitter and Facebook.